Highly avid, oligoclonal, early-differentiated antigen-specific CD8 + T cells in chronic HIV-2 infection

European Journal of Immunology

Volumn 40, Issue 7, 2010, Pages 1963-1972

  Leligdowicz, Aleksandra ^a,b   Onyango, Clayton ^b   Yindom, Louis Marie ^b   Peng, YanChun ^a   Cotten, Matthew ^b   Jaye, Assan ^b   McMichael, Andrew ^a   Whittle, Hilton ^b   Dong, Tao ^a   Rowland Jones, Sarah ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

Cellular immunity; Gag; HIV 2; T cell receptor

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; GAG PROTEIN; GAG PROTEIN P26; GAMMA INTERFERON; HLA B35 ANTIGEN; HLA B3501 ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG; CYTOKINE; DIFFERENTIATION ANTIGEN; GAG PROTEIN P26, HUMAN IMMUNODEFICIENCY VIRUS; HLA B ANTIGEN; HLA-B*35:01 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LEUKOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CLONE; CELL COUNT; CHRONIC DISEASE; DISEASE COURSE; GENETICS; HISTOCOMPATIBILITY TEST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; T LYMPHOCYTE RECEPTOR GENE; VIROLOGY;

AIDS VACCINES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL DIFFERENTIATION; CHRONIC DISEASE; CLONE CELLS; CYTOKINES; DISEASE PROGRESSION; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENES, T-CELL RECEPTOR; HISTOCOMPATIBILITY TESTING; HIV INFECTIONS; HIV-2; HLA-B ANTIGENS; HLA-B35 ANTIGEN; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; T-CELL ANTIGEN RECEPTOR SPECIFICITY;

EID: 77954121799     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200940295     Document Type: Article

References (63)

1. Martinez-Steele, E., Awasana, A. A., Corrah, T., Sabally, S., van der Sande, M., Jaye, A., Togun, T. et al., Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic. AIDS 2007. 21: 317-324.
2. Leligdowicz, A., Yindom, L. M., Onyango, C., Sarge-Njie, R., Alabi, A., Cotten, M., Vincent, T. et al., Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J. Clin. Invest. 2007. 117: 3067-3074.
3. Duvall, M. G., Jaye, A., Dong, T., Brenchley, J. M., Alabi, A. S., Jeffries, D. J., van der Sande, M. et al., Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 2006. 176: 6973-6981.
4. Alatrakchi, N., Damond, F., Matheron, S., Beretta-Tempelhoff, S., Campa, P., Carcelain, G., Brun-Vezinet, F. and Autran, B., Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection. AIDS 2006. 20: 29-34.
5. Rowland-Jones, S., Sutton, J., Ariyoshi, K., Dong, T., Gotch, F., McAdam, S., Whitby, D. et al., HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1995. 1: 59-64.
6. Lopes, A. R., Jaye, A., Dorrell, L., Sabally, S., Alabi, A., Jones, N. A., Flower, D. R. et al., Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection. J. Immunol. 2003. 171: 307-316.
7. Jaye, A., Sarge-Njie, R., Schim van der Loeff, M., Todd, J., Alabi, A., Sabally, S., Corrah, T. and Whittle, H., No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients. J. Infect. Dis. 2004. 189: 498-505.
8. Gillespie, G. M., Pinheiro, S., Sayeid-Al-Jamee, M., Alabi, A., Kaye, S., Sabally, S., Sarge-Njie, R. et al., CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype. Eur. J. Immunol. 2005. 35: 1445-1453.
9. Zheng, N. N., Kiviat, N. B., Sow, P. S., Hawes, S. E., Wilson, A., Diallo- Agne, H., Critchlow, C.W. et al., Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal. J. Virol. 2004. 78: 13934-13942.
10. Gotch, F., McAdam, S. N., Allsopp, C. E., Gallimore, A., Elvin, J., Kieny, M. P., Hill, A. V. et al., Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. J. Immunol. 1993. 151: 3361-3369.
11. Bertoletti, A., Cham, F., McAdam, S., Rostron, T., Rowland-Jones, S., Sabally, S., Corrah, T. et al., Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades. J. Virol. 1998. 72: 2439-2448. (Pubitemid 28100805)
12. Duvall, M. G., Precopio, M. L., Ambrozak, D. A., Jaye, A., McMichael, A. J., Whittle, H. C., Roederer, M. et al., Polyfunctional T cell responses are a hallmark of HIV-2 infection. Eur. J. Immunol. 2008. 38: 350-363.
13. Sousa, A. E., Chaves, A. F., Loureiro, A. and Victorino, R. M., Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. J. Infect. Dis. 2001. 184: 552-559.
14. Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P. et al., Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998. 279: 2103-2106.
15. Ogg, G. S., Kostense, S., Klein, M. R., Jurriaans, S., Hamann, D., McMichael, A. J. and Miedema, F., Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression. J. Virol. 1999. 73: 9153-9160.
16. Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M., Papagno, L., Ogg, G. S. et al., Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 2002. 8: 379-385.
17. Walker, B. D., Chakrabarti, S., Moss, B., Paradis, T. J., Flynn, T., Durno, A. G., Blumberg, R. S. et al., HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987. 328: 345-348.
18. Appay, V., Papagno, L., Spina, C. A., Hansasuta, P., King, A., Jones, L., Ogg, G. S. et al., Dynamics of T cell responses in HIV infection. J. Immunol. 2002. 168: 3660-3666.
19. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. and Ho, D. D., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 1994. 68: 4650-4655. (Pubitemid 24183063)
20. Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M. and Oldstone, M. B., Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 1994. 68: 6103-6110. (Pubitemid 24258634)
21. Walker, C. M., Moody, D. J., Stites, D. P. and Levy, J. A., CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986. 234: 1563-1566.
22. Klein, M. R., van Baalen, C. A., Holwerda, A. M., Kerkhof Garde, S. R., Bende, R. J., Keet, I. P., Eeftinck-Schattenkerk, J. K. et al., Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and longterm asymptomatics. J. Exp. Med. 1995. 181: 1365-1372.
23. Kiepiela, P., Ngumbela, K., Thobakgale, C., Ramduth, D., Honeyborne, I., Moodley, E., Reddy, S. et al., CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 2007. 13: 46-53.
24. Betts, M. R., Ambrozak, D. R., Douek, D. C., Bonhoeffer, S., Brenchley, J. M., Casazza, J. P., Koup, R. A. and Picker, L. J., Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 2001. 75: 11983-11991.
25. Papagno, L., Appay, V., Sutton, J., Rostron, T., Gillespie, G. M., Ogg, G. S., King, A. et al., Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors. Clin. Exp. Immunol. 2002. 130: 509-517.
26. Migueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Van Baarle, D. et al., HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 2002. 3: 1061-1068.
27. Migueles, S. A., Osborne, C. M., Royce, C., Compton, A. A., Joshi, R. P., Weeks, K. A., Rood, J. E. et al., Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity 2008. 29: 1009-1021.
28. Dong, T., Stewart-Jones, G., Chen, N., Easterbrook, P., Xu, X., Papagno, L., Appay, V. et al., HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J. Exp. Med. 2004. 200: 1547-1557.
29. Almeida, J. R., Price, D. A., Papagno, L., Arkoub, Z. A., Sauce, D., Bornstein, E., Asher, T. E. et al., Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 2007. 204: 2473-2485.
30. Betts, M. R., Nason, M. C., West, S. M., De Rosa, S. C., Migueles, S. A., Abraham, J., Lederman, M. M. et al., HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006. 107: 4781-4789.
31. Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R. et al., HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999. 283: 1748-1752.
32. Hendel, H., Caillat-Zucman, S., Lebuanec, H., Carrington, M., O'Brien, S., Andrieu, J. M., Schachter, F. et al., New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J. Immunol. 1999. 162: 6942-6946.
33. Kaslow, R. A., Rivers, C., Tang, J., Bender, T. J., Goepfert, P. A., El Habib, R., Weinhold, K. and Mulligan, M. J., Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. J. Virol. 2001. 75: 8681-8689.
34. Geldmacher, C., Currier, J. R., Herrmann, E., Haule, A., Kuta, E., McCutchan, F., Njovu, L., et al., CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J. Virol. 2007. 81: 2440-2448.
35. Kiepiela, P., Leslie, A. J., Honeyborne, I., Ramduth, D., Thobakgale, C., Chetty, S., Rathnavalu, P. et al., Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004. 432: 769-775.
36. Streeck, H., Lichterfeld, M., Alter, G., Meier, A., Teigen, N., Yassine-Diab, B., Sidhu, H. K. et al., Recognition of a defined region within p24 Gag by CD8+ T cells during primary HIV-1 infection in individuals expressing protective HLA class I alleles. J. Virol. 2007. 81: 7725-7731.
37. Kaul, R., Dong, T., Plummer, F. A., Kimani, J., Rostron, T., Kiama, P., Njagi, E. et al., CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J. Clin. Invest. 2001. 107: 1303-1310.
38. Tomiyama, H., Miwa, K., Shiga, H., Moore, Y. I., Oka, S., Iwamoto, A., Kaneko, Y. and Takiguchi, M., Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS. J. Immunol. 1997. 158: 5026-5034. (Pubitemid 127483829)
39. Jin, X., Gao, X., Ramanathan,M., Jr., Deschenes, G. R., Nelson, G.W., O'Brien, S. J., Goedert, J. J. et al., Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes. J. Virol. 2002. 76: 12603-12610.
40. Gao, X., Nelson, G. W., Karacki, P., Martin, M. P., Phair, J., Kaslow, R., Goedert, J. J. et al., Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 2001. 344: 1668-1675.
41. Allsopp, C. E., Harding, R. M., Taylor, C., Bunce, M., Kwiatkowski, D., Anstey, N., Brewster, D. et al., Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. Am. J. Hum. Genet. 1992. 50: 411-421.
42. Linsley, P. S. and Ledbetter, J. A., The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 1993. 11: 191-212.
43. Appay, V., Nixon, D. F., Donahoe, S. M., Gillespie, G. M., Dong, T., King, A., Ogg, G. S. et al., HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 2000. 192: 63-75.
44. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W. et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006. 443: 350-354.
45. Katsikis, P. D., Wunderlich, E. S., Smith, C. A., Herzenberg, L. A. and Herzenberg, L. A., Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 1995. 181: 2029-2036.
46. Garcia, K. C. and Adams, E. J., How the T cell receptor sees antigen - a structural view. Cell 2005. 122: 333-336.
47. Papagno, L., Spina, C. A., Marchant, A., Salio, M., Rufer, N., Little, S., Dong, T. et al., Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2004. 2: E20.
48. Sauce, D., Almeida, J. R., Larsen, M., Haro, L., Autran, B., Freeman, G. J. and Appay, V., PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status. AIDS 2007. 21: 2005-2013.
49. Betts, M. R., Krowka, J. F., Kepler, T. B., Davidian, M., Christopherson, C., Kwok, S., Louie, L. et al., Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res. Hum. Retroviruses 1999. 15: 1219-1228.
50. Pestka, S., Krause, C. D., Sarkar, D.,Walter, M. R., Shi, Y. and Fisher, P. B., Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004. 22: 929-979.
51. Kalams, S. A., Johnson, R. P., Trocha, A. K., Dynan, M. J., Ngo, H. S., D'Aquila, R. T., Kurnick, J. T. andWalker, B. D., Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 1994. 179: 1261-1271.
52. Moss, P. A., Moots, R. J., Rosenberg, W. M., Rowland-Jones, S. J., Bodmer, H. C., McMichael, A. J. and Bell, J. I., Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc. Natl. Acad. Sci. USA 1991. 88: 8987-8990.
53. Lehner, P. J.,Wang, E. C.,Moss, P.A.,Williams, S., Platt,K., Friedman, S. M., Bell, J. I. and Borysiewicz, L. K., Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J. Exp. Med. 1995. 181: 79-91.
54. Busch, D. H. and Pamer, E. G., T cell affinity maturation by selective expansion during infection. J. Exp. Med. 1999. 189: 701-710.
55. Turner, S. J., Doherty, P. C., McCluskey, J. and Rossjohn, J., Structural determinants of T-cell receptor bias in immunity. Nat. Rev. 2006. 6: 883-894.
56. Pantaleo, G., Demarest, J. F., Soudeyns, H., Graziosi, C., Denis, F., Adelsberger, J. W., Borrow, P. et al., Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994. 370: 463-467.
57. Jallow, S., Kaye, S., Alabi, A., Aveika, A., Sarge-Njie, R., Sabally, S., Corrah, T. et al., Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia. AIDS 2006. 20: 1455-1458.
58. Shimbara, N., Ogawa, K., Hidaka, Y., Nakajima, H., Yamasaki, N., Niwa, S., Tanahashi, N. and Tanaka, K., Contribution of proline residue for efficient production of MHC class I ligands by proteasomes. J. Biol. Chem. 1998. 273: 23062-23071.
59. Leligdowicz, A., Feldmann, J., Jaye, A., Cotten, M., Dong, T., McMichael, A., Whittle, H. and Rowland-Jones, S., Direct relationship between virus load and systemic immune activation in HIV-2 infection. J. Infect. Dis. 2010. 201: 114-122.
60. Bunce, M., O'Neill, C. M., Barnardo, M. C., Krausa, P., Browning, M. J., Morris, P. J. andWelsh, K. I., Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995. 46: 355-367.
61. Addo, M. M., Yu, X. G., Rathod, A., Cohen, D., Eldridge, R. L., Strick, D., Johnston, M. N. et al., Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 2003. 77: 2081-2092.
62. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. and Davis, M. M., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 94-96.
63. Onyango, C., Leligdowicz, A., Yokoyama, M., Sato, H., Song, H., Nakayama, E. E., Shoida, T. et al., HIV-2 capsids distinguish high and low virus load patients in aWest African community cohort. Vaccine 2010. 28: B60-B67.